authors recommend caution given evidence quality No completed Phase II/III human trials
10 mg / 2 mL = 5 mg/mL 2 mg = 2,000 mcg 2,000 mcg / 5,000 mcg per mL = 0.4 mL = 40 U-100 units Retatrutide 5 mg vial with 2 mL example A 5 mg retatrutide vial mixed with 2 mL gives 2.5 mg/mL, or 2,500 mcg/mL half the concentration of the 10 mg example
Some of the ongoing research directions include: Long-term safety and efficacy: As BPC-157 is a relatively new compound, long-term studies are needed to establish its safety and efficacy in various populations and for different indications
Each 1 mL contains a potent 20 mg of Retatrutide
Only microcrystalline cellulose is used, minimizing assay interference
For someone planning to use this consistently over multiple months - which the four-to-eight week evaluation recommendation implies - the subscription pricing represents a meaningful reduction in cost per bottle